FHIR IG analytics| Package | hl7.fhir.uv.xver-r4.r4b.r4b |
| Resource Type | ValueSet |
| Id | ValueSet-R4-v2-0252-for-R4B.json |
| FHIR Version | R4B |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet R4-v2-0252-for-R4B
This value set expansion contains 11 concepts.
| Code | System | Display |
| AW | http://terminology.hl7.org/CodeSystem/v2-0252 | Abatement of event after product withdrawn |
| BE | http://terminology.hl7.org/CodeSystem/v2-0252 | Event recurred after product reintroduced |
| DR | http://terminology.hl7.org/CodeSystem/v2-0252 | Dose response observed |
| EX | http://terminology.hl7.org/CodeSystem/v2-0252 | Alternative explanations for the event available |
| IN | http://terminology.hl7.org/CodeSystem/v2-0252 | Event occurred after product introduced |
| LI | http://terminology.hl7.org/CodeSystem/v2-0252 | Literature reports association of product with event |
| OE | http://terminology.hl7.org/CodeSystem/v2-0252 | Occurrence of event was confirmed by objective evidence |
| OT | http://terminology.hl7.org/CodeSystem/v2-0252 | Other |
| PL | http://terminology.hl7.org/CodeSystem/v2-0252 | Effect observed when patient receives placebo |
| SE | http://terminology.hl7.org/CodeSystem/v2-0252 | Similar events in past for this patient |
| TC | http://terminology.hl7.org/CodeSystem/v2-0252 | Toxic levels of product documented in blood or body fluids |
{
"resourceType": "ValueSet",
"id": "R4-v2-0252-for-R4B",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger": 0
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode": "fhir"
},
{
"extension": [
{
"url": "packageId",
"valueId": "hl7.fhir.uv.xver-r4.r4b"
},
{
"url": "version",
"valueString": "0.0.1-snapshot-2"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/package-source"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode": "trial-use",
"_valueCode": {
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical": "http://hl7.org/fhir/4.0/ImplementationGuide/hl7.fhir.uv.xver-r4.r4b"
}
]
}
}
],
"url": "http://hl7.org/fhir/4.0/ValueSet/R4-v2-0252-for-R4B",
"version": "0.0.1-snapshot-2",
"name": "R4_v2_0252_for_R4B",
"title": "Cross-version VS for R4.v2.0252 for use in FHIR R4B",
"status": "active",
"experimental": false,
"date": "2025-09-01T22:36:18.413175+10:00",
"publisher": "FHIR Infrastructure",
"contact": [
{
"name": "FHIR Infrastructure",
"telecom": [
{
"system": "url",
"value": "http://www.hl7.org/Special/committees/fiwg"
}
]
}
],
"description": "This cross-version ValueSet represents concepts from http://terminology.hl7.org/ValueSet/v2-0252|2.9 for use in FHIR R4B. Concepts not present here have direct `equivalent` mappings crossing all versions from R4 to R4B.",
"jurisdiction": [
{
"coding": [
{
"system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code": "001",
"display": "World"
}
]
}
],
"compose": {
"include": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0252",
"version": "2.9",
"concept": [
{
"code": "AW",
"display": "Abatement of event after product withdrawn"
},
{
"code": "BE",
"display": "Event recurred after product reintroduced"
},
{
"code": "DR",
"display": "Dose response observed"
},
{
"code": "EX",
"display": "Alternative explanations for the event available"
},
{
"code": "IN",
"display": "Event occurred after product introduced"
},
{
"code": "LI",
"display": "Literature reports association of product with event"
},
{
"code": "OE",
"display": "Occurrence of event was confirmed by objective evidence"
},
{
"code": "OT",
"display": "Other"
},
{
"code": "PL",
"display": "Effect observed when patient receives placebo"
},
{
"code": "SE",
"display": "Similar events in past for this patient"
},
{
"code": "TC",
"display": "Toxic levels of product documented in blood or body fluids"
}
]
}
]
},
"expansion": {
"timestamp": "2025-09-01T22:36:18.413179+10:00",
"contains": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0252",
"version": "2.9",
"code": "AW",
"display": "Abatement of event after product withdrawn"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0252",
"version": "2.9",
"code": "BE",
"display": "Event recurred after product reintroduced"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0252",
"version": "2.9",
"code": "DR",
"display": "Dose response observed"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0252",
"version": "2.9",
"code": "EX",
"display": "Alternative explanations for the event available"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0252",
"version": "2.9",
"code": "IN",
"display": "Event occurred after product introduced"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0252",
"version": "2.9",
"code": "LI",
"display": "Literature reports association of product with event"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0252",
"version": "2.9",
"code": "OE",
"display": "Occurrence of event was confirmed by objective evidence"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0252",
"version": "2.9",
"code": "OT",
"display": "Other"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0252",
"version": "2.9",
"code": "PL",
"display": "Effect observed when patient receives placebo"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0252",
"version": "2.9",
"code": "SE",
"display": "Similar events in past for this patient"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0252",
"version": "2.9",
"code": "TC",
"display": "Toxic levels of product documented in blood or body fluids"
}
]
}
}